Executive Vice President, Research and Chief Scientific Officer
Hyam Levitsky received an average compensation of $8,135,819 at Juno Therapeutics between 2015 and 2016.
|Non-Equity Incentive Plan||$131,840|
In 2016, Hyam Levitsky earned a total compensation of $2,129,146 as Executive Vice President, Research and Chief Scientific Officer at Juno Therapeutics, Inc..
Levitsky received $1,534,750 in option awards, which accounts for 72.08% of total compensation.
Levitsky also received $28,000 in bonus, $131,840 in non-equity incentive plan, $390,692 in salary and $43,864 in other compensation.